Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of High-Dose Methotrexate in Children With Residual Ependymoma

NCT00287924 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00287924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of High-Dose Methotrexate in Children With Residual Ependymoma
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2005
Completion date
Not reported
Enrollment
29 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors